For Quick Alerts
For Daily Alerts

These 2 Sectors Only Saw Buying Interest Of FPIs In March Quarter


In the quarter ended March, foreign portfolio investors sold big time into Indian equities, but amid the rout spurred more in February-March due to the Covid 19 pandemic, saw buying interest mainly in pharma and NBFC space.

This is as per the latest FPI holding in Indian stocks and has upped their stake by 500 bps in some of the financial and pharma counters.

These 2 Sectors Only Saw Buying Interest Of FPIs In March Quarter

Among these while pharma stocks over outshined most sectors due to ease in regulations as well as increase in demand for pharma products due to Covid 19, NBFC space has bore the brunt with stocks tumbling up to 50% on rising concerns on mounting bad loans as well as liquidity concerns due to prolonged lockdown situation in the domestic economy similar to other nations.

Nonetheless, analyst warned investors to be careful while picking stocks from both the space.

NBFCs where FPIs increased their holding in March ended quarter

NBFC FPI holding in March qtr in % FPI holding in December qtr in % Closing price as on April 30, 2020
Aavas Financiers 23.64 18.79 Rs. 1197.05
Ujjivan Financial Services
22.46 18.87 Rs. 176.10
Max Financial Services
30.61 27.74 Rs. 470.55
Equitas Holdings
28.67 26.08 Rs. 51.60

During the quarter, they sold into Indian equities worth Rs. 48,030 crore.

Pharma players where FPIs increase their stake

Pharma company FPI holding in March qtr in % FPI holding in December qtr in % Closing price as on April 30, 2020
Granules India
21.70 17.74 Rs. 162.5
Strides Pharma
28.80 27.16 Rs 443.6

The other pharma names where FPIs have raised their stake sequentially by between 90-150 bps include Eris Lifesciences, Dishman Caebogen, Ajanta Pharma and Alkem Laboratories.

Outlook for Nifty and Pharma stocks going ahead:

In the current unprecedented, for the NBFC counters, it is strictly adviced to bet only on those names that have well-managed asset-liability management together with strong promoter betting i.e. precisely larger counters. This is because small players will find difficult to mop-up funds.


For the pharma stocks, the time is highly lucrative as the government may ease further regulation and indeed provide support for setting up API units within the shore.

Read more about: stock markets fpi
Story first published: Thursday, April 30, 2020, 16:41 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more